SEC Form 4 · accession 0001127602-18-021987
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Raymond Dwek
Director
Period of report
Jun 26, 2018
Accepted (ET)
Jun 28, 2018 · 7:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 28, 2018 | M | 3,240 | $0.00 | A | 3,240 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF3,F2,F4 | $0.00 | Jun 26, 2018 | A | 3,750 | A | — | — | Common Stock | 3,750 | 3,750 | D |
| Restricted Stock UnitsF2,F4 | $0.00 | Jun 28, 2018 | M | 3,240 | D | — | — | Common Stock | 3,240 | 0 | D |
Explanation of responses
- F1Shares received upon vesting of restricted stock units on June 28, 2018. Restricted stock units converted on a one-for-one basis into shares of common stock.
- F2Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.
- F3Annual non-employee director grant of restricted stock units, which are awarded and priced each year on the date of the issuer's Annual Meeting of Shareholders.
- F4The restricted stock units vest on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. Shares will be issued to the reporting person upon vesting unless the reporting person has elected to defer receipt of shares.